Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Neoplasms 12 Lung Neoplasms 11 Endometrial Neoplasms 11 Stomach Neoplasms 10 Lymphatic Metastasis 7 Head and Neck Neoplasms 7 Melanoma 6 Esophageal Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Ovarian Neoplasms 4 Sarcoma 3 Prostatic Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Vulvar Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2 Margins of Excision 2 Giant Cell Tumor of Bone 2

Interventions

Irinotecan 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Oxaliplatin 4 Fluorouracil 4 Capecitabine 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 napabucasin 3 Ocoxin 3 Leucovorin 3 pembrolizumab 2 Sorafenib 2 Paclitaxel 2 Nivolumab 2 Cyclophosphamide 2 Cetuximab 2 Bupivacaine 2 Aspirin 2 Ascorbic Acid 2 trifluridine tipiracil drug combination 1 trametinib 1 pralsetinib 1 penpulimab 1 ozanimod 1 linifanib 1 hetrombopag 1 halofantrine 1 guadecitabine 1 golotimod 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Digestive System Diseases × Indocyanine Green × Clear all

NCT05228587 2022-03-04

LivInG

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown

Digestive System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡